Table: Kyorin Pharmaceutical -2025/26 group results

Kyorin Pharmaceutical

12/05/2026 07:33

May 12 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales          126.26          130.09         121.80         57.80    
               (-2.9 pct)      (+8.8 pct)     (-3.5 pct)    (-1.6 pct)  
  Operating        3.57           12.57           2.00     loss 300 mln 
               (-71.6 pct)    (+101.6 pct)    (-43.9 pct)               
  Recurring        4.03           13.22           2.30     loss 100 mln 
               (-69.5 pct)     (+93.8 pct)    (-42.9 pct)               
  Net
  Net              3.45            9.09           1.50         0 mln    
               (-62.0 pct)     (+66.0 pct)    (-56.5 pct)  (-100.0 pct) 
  EPS           60.03 yen      158.17 yen      26.11 yen        NIL     
  Ann Div       57.00 yen       57.00 yen      25.00 yen                
  -Q2 Div       20.00 yen       20.00 yen      10.00 yen                
  -Q4 Div       37.00 yen       37.00 yen      15.00 yen                
  
  NOTE - Kyorin Pharmaceutical Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T